| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
| 01/12/2011 | EP2272831A1 Process for the preparation of arylpyridinyl compounds |
| 01/12/2011 | EP2272830A1 Preparation process of an antivirally heterocyclic azahexane derivative |
| 01/12/2011 | EP2272826A1 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
| 01/12/2011 | EP2272822A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2271642A2 Pyridyl inhibitors of hedgehog signalling |
| 01/12/2011 | EP2271624A1 Iminopyridine derivatives and use thereof |
| 01/12/2011 | EP2271623A2 Perpropionic acid composition that is stable in a basic medium |
| 01/12/2011 | EP2271622A2 Heteroaryl derivatives as cftr modulators |
| 01/12/2011 | EP2271621A1 Pyridyl derivatives as cftr modulators |
| 01/12/2011 | EP2271620A1 Compositions and methods for inhibition of hepatocyte growth factory receptor c-met signaling |
| 01/12/2011 | EP1797062B1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | CN1826098B Production of small particles |
| 01/12/2011 | CN101945859A Bis-(sulfonylamino) derivatives in therapy |
| 01/12/2011 | CN101941943A Synthesis method of 2-chlorine-3-cyanopyridine |
| 01/12/2011 | CN101941942A Industrialized method for preparing 2-mercaptopyridine |
| 01/12/2011 | CN101941941A Carboxylic ester compound and applications thereof |
| 01/12/2011 | CN101941940A 3,5,6-trichloropyridin-2-ol sodium high-boiling solid waste conversion method |
| 01/12/2011 | CN101941917A Amide compounds and use thereof |
| 01/12/2011 | CN101597258B Technique for synthesizing niacinamide and co-producing niacin by hydrolyzing 3-cyanopyridine |
| 01/12/2011 | CN101514185B Preparation of 2-chloro-3-pyridinamine |
| 01/12/2011 | CN101414662B Organic electronic transmission and/or positive hole countercheck material, and synthesizing method and purpose thereof |
| 01/12/2011 | CN101379035B Improved method for producing nitroguanidine derivative |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/12/2011 | CN101010276B Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868026 Therapeutic compounds |
| 01/11/2011 | US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 01/11/2011 | US7867999 Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
| 01/11/2011 | US7867629 2,4-Diphenyl-6-(10-phenyl-anthracen-9-yl-pyrimidine; achieves elevation of luminance; excellent efficiency of light emission; long lifetime by an improvement of an electrode adhesion; durability; stability; OLED/organic light emitters |
| 01/11/2011 | US7867516 Tablet with masked odor or bitterness; especially with a photostabilizer |
| 01/11/2011 | CA2534088C 2,3-substituted pryidl compounds useful for treating pain |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2461439C Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives |
| 01/11/2011 | CA2456426C New mandelic acid derivatives and their use as thrombin inhibitors |
| 01/11/2011 | CA2439756C Substituted aminodicarboxylic acid derivatives with pharmaceutical properties |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
| 01/06/2011 | WO2011001741A1 Novel organic compound and organic light-emitting device |
| 01/06/2011 | WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011000459A1 Continuous method for producing amides of aromatic carboxylic acids |
| 01/06/2011 | WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | WO2010109084A3 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | US20110003999 Process for Preparing Substituted Biphenylanilides |
| 01/06/2011 | US20110003997 Process for the synthesis of 3-methyl-pyridine |
| 01/06/2011 | US20110003992 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors |
| 01/06/2011 | US20110003867 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003866 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003865 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003863 Method for synthesizing pirfenidone |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003859 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer |
| 01/06/2011 | US20110003852 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/06/2011 | US20110003827 HIV protease inhibiting compounds |
| 01/06/2011 | US20110003826 Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003397 Solvatochromic functional monomer and the use thereof for chemosensing by solvatochromic molecular imprinting |
| 01/06/2011 | US20110003011 Fungicidal active compound combinations |
| 01/06/2011 | CA2767130A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | CA2766955A1 Continuous method for producing esters of aromatic carboxylic acids |
| 01/06/2011 | CA2766926A1 Continuous method for producing amides of aromatic carboxylic acids |
| 01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
| 01/06/2011 | CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2269989A1 Iminopyridine derivative and use thereof |
| 01/05/2011 | EP2269988A2 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP2269987A1 Substituted bipyridyl compound and organic electroluminescent element |
| 01/05/2011 | EP2269986A1 Manufacturing method for a piperidine-3-ylcarbamate compound and optical resolution method therefor |
| 01/05/2011 | EP2269977A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 01/05/2011 | EP2269609A2 Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
| 01/05/2011 | EP2268625A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof |
| 01/05/2011 | EP2268615A1 Pesticides |
| 01/05/2011 | EP2268612A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/05/2011 | EP2268606A1 4-dimethylaminobutyric acid derivatives |
| 01/05/2011 | EP1827501B1 Stabilized polymeric thiol reagents |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | CN101939304A Process for making triphenylboron-pyridine compound |
| 01/05/2011 | CN101939299A Inhibitors for brassinosteroid signalling |
| 01/05/2011 | CN101939298A Process for preparing pyridone derivatives |
| 01/05/2011 | CN101935300A Preparation method of high-purity organic chelated chromium nicotinate |
| 01/05/2011 | CN101935299A Organic electron transport and/or cavitation block material and synthesis method and application thereof |
| 01/05/2011 | CN101935298A Bipiridine derivative and organic electroluminescence element containing the same |
| 01/05/2011 | CN101935291A Cyano phthalic diamide compounds, preparation method thereof and use thereof as agricultural chemical pesticide |
| 01/05/2011 | CN101935285A Hexafluoroaluminate of organic onium, and preparation method and application thereof |
| 01/05/2011 | CN101934235A Ethylene oligomerization catalyst, synthetic method and application |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863458 Halogen-free ionic liquids |
| 01/04/2011 | US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 01/04/2011 | US7863332 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 01/04/2011 | US7863313 Methods for the treatment of inflammatory diseases |
| 01/04/2011 | US7863300 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione |
| 01/04/2011 | US7863293 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count |
| 01/04/2011 | US7863269 Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 01/04/2011 | CA2545813C The derivatives of pyridone and use thereof |